Previous terms
continue: OMB approves this collection for a period of three years.
To request approval of information collections under this generic
approval, the agency must do the following: 1) Unless an agency is
using multiple modes of collection (e.g., paper forms and
electronic submissions), provide a Generic Clearance Submission
Template for each Instrument; 2) If the agency is using multiple
modes of collection (e.g., paper forms and electronic submissions),
the same Generic Clearance Submission Template may be used for both
instruments; 3) each Generic Clearance Submission Template must be
uploaded as a Supplementary document using a naming convention that
allows the public to identify the associated instrument; 4) submit
no more than five Generic Submission Templates with each
request.
Inventory as of this Action
Requested
Previously Approved
03/31/2023
36 Months From Approved
05/31/2020
100,800
0
49,500
28,011
0
26,751
0
0
0
Department of Health and Human
Services (DHHS), National Institutes of Health (NIH), National
Cancer Institute (NCI), seeks to obtain OMB approval to extend the
generic clearance to collect qualitative feedback on our service
delivery for an additional three (3) years. This generic has
provided information about the National Cancer Institute’s customer
or stakeholder perceptions, experiences and expectations, provide
an early warning of issues with service, or focus attention on
areas where communication, training or changes in operations might
improve delivery of products or services. It has also allowed
feedback to contribute directly to the improvement of program
management. Feedback collected under this generic clearance
provides useful information but it does not yield data that can be
generalized to the overall population.
EO: EO
12862 Name/Subject of EO: SETTING CUSTOMER SERVICE STANDARDS
This is an Extension of a
currently approved submission. There are no substantive changes to
this submission, however the burden hours have increased by 420
hours. NCI, through various outreach meetings and discussions have
increased the visibility of the PRA program. This outreach has led
to an increase in requests and is projected to continue as more
departments, offices, and centers become aware of the process .
This is the difference of the previously approved 8,917 minus the
proposed, 9,337. The total number of respondents has increased by
17,100 from 10,000 to 27,100. This increase is to account for the
increased survey activities that are planned
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.
Form 1 Division of Cancer Control and Population Sciences (DCCPS) Future of Cancer Health Economics Research Conference Feedback (NCI)
published 30day FRN2020-02913.pdf
SSA Generic NCI Fast Track Extension.docx
Division of Cancer Control and Population Sciences (DCCPS) Future of Cancer Health Economics Research Conference Feedback (NCI)